Next, we distinguished a prognostic risk signature with eight identified m6A regulators (METTL14, ZC3H13, FTO, YTHDF1, YTHDF3, HNRNPA2B1, LRPPRC, and ELAVL1), which divided the OS in ACC into high-risk subgroups with high mortality and low-risk subgroup with remarkably better survival. This evidence concerns the gene HNRNPA2B1 and adrenal cortex carcinoma.